Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNichols plc Regulatory News (NICL)

Share Price Information for Nichols plc (NICL)

Share Price is delayed by 15 minutes
Get Live Data
944.00    2.00 (0.21%)
Bid:
940.00
Ask:
954.00
Spread: 14.00 (1.489%)
Market Cap: £345.17m
NICL Live PriceLast checked at - London Stock Exchange

Intraday Nichols plc Share Chart

AGM Trading Update

21 Apr 2026 07:00

RNS Number : 2082B
Nichols PLC
21 April 2026
Β 

(the "Company" or "Group")

AGM Trading Update

Positive start to the year; trading in line with expectations and full-year guidance reiterated

Β 

Nichols plc, the diversified soft drinks Group, provides the following trading update for the three months to 31st March 2026 ("the Period"), to coincide with the Company's Annual General Meeting ("AGM") taking place later today.

Group revenue grew 4.3% year-on-year in the Period to Β£41.0m (2025: Β£39.3m), an encouraging start to the year in-line with the Board's expectations.

Total Packaged revenues grew by 5.6% driven by pleasing performances in both the UK and International markets.

UK Packaged revenues increased by 3.8% to Β£22.1m (2025: Β£21.3m), reflecting a continued focus on innovation which is expected to continue to contribute positively in the year ahead.

International Packaged revenues increased by 11.1% to Β£10.0m (2025: Β£9.0m), with growth driven almost entirely by West Africa. This strong performance is being delivered through a combination of accelerated can export sales and the ongoing shift to a concentrate model. This was partially offset by lower Middle East revenues, as planned, due to the timing of shipments which are weighted towards the second half of the year.

Out of Home revenues decreased by 3.3% to Β£8.7m (2025: Β£9.0m), in line with expectations, driven entirely by the planned exit of the lower-margin Starslush business and a strategic focus on profitability.

The Group retains a very strong balance sheet with net cash and cash equivalents at the end of the Period of Β£59.8m (31 December 2025: Β£55.7m). This increase reflects year-end movements in working capital unwinding as expected, as well as the conclusion of investment in the business change programme.

Board

As previously announced, Matthew Rothwell joined the Group as Chief Financial Officer on 13 April 2026 and is expected to join the Board following shareholder approval at today's AGM.

Outlook

The Group's FY261 revenue and adjusted PBT1 expectations are unchanged.

The Board continues to monitor developments arising from the conflict in the Middle East, which may lead to some volatility in supply chains and key input costs. While there has been no material impact on the business to date, the Group is taking proactive steps to manage potential disruption, with mitigation plans in place and some near-term protection against cost inflation in H1 through contractual cover.

As previously indicated, the International Packaged business is expected to be weighted towards the second half of the year, driven primarily by the timing of concentrate shipments to Africa and, to a lesser extent, the timing of shipments to the Middle East, which commence later in the year, principally as a result of the phasing of Ramadan. This will impact the half-year profile. As a result, the Group expects performance to be weighted towards the second half with first half profitability expected to be modestly below the prior year. Full year expectations remain unchanged with positive trading momentum set to continue as we complete Phase 2 of our concentrate model shift.

Underpinned by the strength of the Vimto brand, the Group's diversified and asset-light business model and clear growth strategy, the Group is well positioned to deliver continued profitable growth in line with its medium-term financial and strategic ambitions.

Andrew Milne, Chief Executive Officer of Nichols, commented:

"We are pleased to have delivered a strong start to the year, with continued revenue growth and further strategic progress in Q1. Our UK Packaged business performed well driven by successful innovation and clear execution against the strategic priorities outlined at our 2024 Capital Markets Day.

In the International Packaged business, our planned strategic shift towards a higher margin concentrate model in several of our West African markets is delivering a step change in margins and positions us well to deliver long-term, profitable growth. Whilst the Middle East conflict has had a limited impact on performance to date, we are taking proactive steps to manage potential disruption, with contingency plans in place to mitigate any associated commodity cost inflation. Our distribution routes do not have direct exposure to the most affected shipping corridors in the region.

I am delighted to have welcomed Matt Rothwell into the business as our new CFO, providing considerable experience and expertise, and we look forward to benefitting from this during the years ahead.

We continue to expect growth and performance in FY26 in line with market expectations as we execute our strategic priorities and deliver further progress towards our medium-term financial and strategic ambitions."

Β 

1 FY26 expectations refer to a Group compiled market consensus of Revenue Β£183.1m and adjusted PBT Β£35.3m

Β 

Β 

Contacts

Nichols plc

Andrew Milne, Chief Executive Officer

Matthew Rothwell, Chief Financial Officer

Β 

Telephone: 0192 522 2222

Singer Capital Markets (NOMAD & Broker)

Jen Boorer / Sara Hale

Β 

Telephone: 0207 496 3000

Website:Β www.singercm.com

Joh. Berenberg, Gossler & Co KG, London (Joint Broker)

Clayton Bush / Alix Mecklenburg-Solodkoff

Β 

Telephone: 0203 207 7800

Hudson Sandler (Financial PR)

Alex Brennan / Hattie Dreyfus / Harry Griffiths

Β 

Β 

Telephone: 0207 796 4133

Email:Β nichols@hudsonsandler.com

Β 

Β 

Notes to EditorsΒ 

Established in 1908, Nichols operates within the resilient soft drinks category and owns or licenses several brands. Nichols is geographically and operationally diversified, operating across three routes to market of UK Packaged, International Packaged and Out of Home.

In the UK, Nichols operates across five soft drinks sub-categories: squash, flavoured carbonates, fruit drinks, energy and flavoured water. Nichols' portfolio includes the iconic Vimto brand plus a growing portfolio of licensed brands including Levi Roots, ICEE, SLUSH PUPPiE and Sunkist.

Under its asset-light model, Vimto is prominent in areas such as the Middle East and Africa and is enjoyed in over 60 countries worldwide.

For more information, visit the website:Β https://www.nicholsplc.co.uk/

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTEANLEASEKEFA
Date   Source Headline
3rd Jun 20267:00 amRNSGrant of SAYE Options and PDMR Dealings
3rd Jun 20267:00 amRNSExercise of Options and Director/PDMR Dealings
27th May 20263:13 pmRNSHolding(s) in Company
24th Apr 20267:00 amRNSGrant of Options
22nd Apr 20263:21 pmRNSHolding(s) in Company
21st Apr 20265:59 pmRNSResult of AGM
21st Apr 20267:00 amRNSAGM Trading Update
20th Apr 20267:00 amRNSConcert Party Shareholding
24th Mar 20267:00 amRNSGrant of Options
23rd Mar 20267:00 amRNSPublication of Annual Report and Notice of AGM
17th Mar 20267:00 amRNSGrant of Options
17th Mar 20267:00 amRNSGrant of Options
11th Mar 20267:00 amRNS2025 Preliminary Results
6th Mar 20267:00 amRNS-RNotice of Results and Investor Presentation
14th Jan 20267:00 amRNSFY25 Trading Update
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
12th Dec 20252:46 pmRNSDirector/PDMR Dealing
12th Dec 20257:00 amRNSGrant of Share Award
1st Dec 20255:00 pmRNSDirector Shareholding
1st Dec 20255:00 pmRNSHoldings in Company
11th Nov 20257:00 amRNSAppointment of Chief Financial Officer
29th Sep 20252:16 pmRNSHolding(s) in Company
8th Aug 20252:59 pmRNSDirector/PDMR Dealing
7th Aug 202510:26 amRNSDirector/PDMR Dealing
31st Jul 20257:00 amRNS2025 Interim Results
23rd Jul 20257:00 amRNS-RNotice of Results and Investor Presentation
16th Jun 20252:08 pmRNSHolding(s) in Company
11th Jun 20252:45 pmRNSExercise of Options and Director / PDMR Dealing
9th Jun 20255:25 pmRNSHolding(s) in Company
29th May 20254:53 pmRNSExercise of Options, Director/PDMR Dealing & TVR
6th May 20252:44 pmRNSHolding(s) in Company
2nd May 20258:25 amRNSHolding(s) in Company
29th Apr 20253:15 pmRNSGrant of SAYE Options and PDMR Dealings
28th Apr 20254:45 pmRNSHolding(s) in Company
23rd Apr 20255:40 pmRNSResult of Annual General Meeting
23rd Apr 20257:00 amRNSAGM Trading Update
1st Apr 20253:20 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSPublication of Annual Report & Notice of AGM
26th Mar 20257:00 amRNSHolding(s) in Company
26th Mar 20257:00 amRNSGrant of Options & PDMR Dealings
17th Mar 20253:43 pmRNSNotification of the passing of Richard Newman, CFO
11th Mar 20257:00 amRNS2024 Preliminary Results
11th Mar 20257:00 amRNSNon-Executive Board Changes
6th Mar 202511:42 amRNS-RNotice of Results and Investor Presentation
3rd Feb 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Jan 20257:00 amRNSBoard Responsibilities
15th Jan 20257:00 amRNSFY24 Trading Update
6th Nov 20247:00 amRNSCapital Markets Day & Medium-Term Ambitions
31st Oct 20244:29 pmRNSDirector Shareholding
24th Oct 20242:00 pmRNSNotice of CMD & Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.